Juno Therapeutics Stops Trial Of Cancer-Killing Cells After 3 Patient Deaths - Forbes

FTSE News

Juno Therapeutics Stops Trial Of Cancer-Killing Cells After 3 Patient Deaths Forbes Three patients have died in a closely watched study of using genetically engineered white blood cells to treat adult leukemia patients, forcing the trial to be put on hold. The news is a blow for Juno Therapeutics, the biotechnology startup valued at ... Juno Therapeutics Reports Clinical Hold on the JCAR015 Phase II ROCKET TrialBusiness Wire (press release) Juno Says Two Patients in Clinical Trial Died, Tests on HoldBloomberg FDA puts Juno's drug trial on hold after two patients dieYahoo Finance Market Digest -FTSE News all 8 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNFNCrVIzVVcceOx9PxpseneJ0OnnA&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779151630272&ei=27x-V5DrIMXRpwfS4KbIAQ&url=http://www.forbes.com/sites/matthewherper/2016/07/07/juno-therapeutics-stops-trial-of-cancer-killing-cells-after-3-patient-deaths/
via IFTTT